Literature DB >> 8013754

The relation of diabetes to the severity of acute myocardial infarction and post-myocardial infarction survival in Mexican-Americans and non-Hispanic whites. The Corpus Christi Heart Project.

P R Orlander1, D C Goff, M Morrissey, D J Ramsey, M L Wear, D R Labarthe, M Z Nichaman.   

Abstract

The effect of diabetes on survival after myocardial infarction (MI) was examined in a prospective population-based study of individuals hospitalized with MI in a bi-ethnic community of Mexican-Americans and non-Hispanic whites. Among Mexican-Americans, 54% (331 of 610) had diabetes compared with 33% (192 of 589) of non-Hispanic whites (P < 0.001). Among those with diabetes, the prevalence of a history of a cardiac event before the index admission was significantly higher (odds ratio = 1.4, 95% confidence interval [CI] 1.1-1.8) than among nondiabetic subjects. During the index hospitalization, diabetic subjects received cardiac catheterization less frequently than did nondiabetic subjects (45.1 vs. 51.5%, P = 0.03). Diabetic subjects had lower estimated ejection fractions, and the number of coronary arteries with significant obstruction (> 75%) was higher (P < 0.001). The peak creatine phosphokinase and creatine phosphokinase myocardial isoenzyme (CK-MB) levels were similar in diabetic and nondiabetic subjects. Despite a similar infarct size, diabetic subjects had a higher incidence of congestive heart failure (relative ratio = 2.2, 95% CI 1.7-2.8), more adverse indexes of short-term and long-term prognosis, and a longer average hospital stay (12.1 vs. 8.9 days, P < 0.01). After adjustment for age, sex, and ethnicity, the cumulative risk for total mortality, over 44 months of follow-up, was 37.4% among diabetic compared with 23.3% among nondiabetic subjects (P < 0.001). Diabetic subjects had a higher 28-day case-fatality rate post-MI as well as higher long-term mortality.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8013754     DOI: 10.2337/diab.43.7.897

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  13 in total

1.  C1q/Tumor Necrosis Factor-Related Protein 9 Protects against Acute Myocardial Injury through an Adiponectin Receptor I-AMPK-Dependent Mechanism.

Authors:  Takahiro Kambara; Rei Shibata; Koji Ohashi; Kazuhiro Matsuo; Mizuho Hiramatsu-Ito; Takashi Enomoto; Daisuke Yuasa; Masanori Ito; Satoko Hayakawa; Hayato Ogawa; Tamar Aprahamian; Kenneth Walsh; Toyoaki Murohara; Noriyuki Ouchi
Journal:  Mol Cell Biol       Date:  2015-04-13       Impact factor: 4.272

2.  Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms.

Authors:  Rei Shibata; Kaori Sato; David R Pimentel; Yukihiro Takemura; Shinji Kihara; Koji Ohashi; Tohru Funahashi; Noriyuki Ouchi; Kenneth Walsh
Journal:  Nat Med       Date:  2005-09-11       Impact factor: 53.440

3.  Insulin infusion in diabetic patients with acute myocardial infarction.

Authors:  G Davey; P Mckeigue
Journal:  BMJ       Date:  1996-09-14

Review 4.  Strategies for the management of diabetic dyslipidaemia.

Authors:  M R Taskinen
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 5.  Adiponectin actions in the cardiovascular system.

Authors:  Teresa A Hopkins; Noriyuki Ouchi; Rei Shibata; Kenneth Walsh
Journal:  Cardiovasc Res       Date:  2006-10-20       Impact factor: 10.787

Review 6.  Cardioprotection by adiponectin.

Authors:  Noriyuki Ouchi; Rei Shibata; Kenneth Walsh
Journal:  Trends Cardiovasc Med       Date:  2006-07       Impact factor: 6.677

7.  Impact of a single intracoronary administration of adiponectin on myocardial ischemia/reperfusion injury in a pig model.

Authors:  Kazuhisa Kondo; Rei Shibata; Kazumasa Unno; Masayuki Shimano; Masakazu Ishii; Tetsutaro Kito; Satoshi Shintani; Kenneth Walsh; Noriyuki Ouchi; Toyoaki Murohara
Journal:  Circ Cardiovasc Interv       Date:  2010-03-23       Impact factor: 6.546

8.  Effect of acute hyperglycaemia and diabetes mellitus with and without short-term insulin treatment on myocardial ischaemic late preconditioning in the rabbit heart in vivo.

Authors:  Dirk Ebel; Jost Müllenheim; Jan Frässdorf; Andre Heinen; Ragnar Huhn; Thomas Bohlen; Jan Ferrari; Hendrik Südkamp; Benedikt Preckel; Wolfgang Schlack; Volker Thämer
Journal:  Pflugers Arch       Date:  2003-03-26       Impact factor: 3.657

Review 9.  Diabetic heart dysfunction: is cell transplantation a potential therapy?

Authors:  Joel Price; Subodh Verma; Ren-Ke Li
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

10.  Effect of second-generation sulfonylureas on survival in patients with diabetes mellitus after myocardial infarction.

Authors:  Adelaide M Arruda-Olson; Richard K Patch; Cynthia L Leibson; Adrian Vella; Robert L Frye; Susan A Weston; Jill M Killian; Véronique L Roger
Journal:  Mayo Clin Proc       Date:  2009       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.